Clinical Study

Eisai: Initiation of New Phase III Clinical Study (Ahead 3-45) of ban2401 Preclinical (Asymptomatic) Alzheimer’s Disease

New Delhi, July 14, 2020: The Alzheimer's Clinical Trials Consortium (ACTC), Eisai Co., Ltd., and Biogen Inc. announced today that…

4 years ago

Eisai to Give Oral Presentation on Results of Phase III Head-to-Head Clinical Study of Lemborexant in Insomnia Disorder

At 43rd Annual Meeting of The Japan Society of Sleep Research At “Drug Discovery Research For Sleep Medicine” Symposium Tokyo,…

6 years ago